-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, QNSK6jtSXnzcN8F3B3RfB7KTHmLNFFNjcX5ARRB2RoV/zNKtNoFERs6GeKSZZRzb Xdn1ZLtM1XASTRs6SWN7hA== 0001179110-08-005608.txt : 20080311 0001179110-08-005608.hdr.sgml : 20080311 20080311164102 ACCESSION NUMBER: 0001179110-08-005608 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080307 FILED AS OF DATE: 20080311 DATE AS OF CHANGE: 20080311 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AVANT IMMUNOTHERAPEUTICS INC CENTRAL INDEX KEY: 0000744218 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 133191702 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 119 FOURTH AVE CITY: NEEDHAM STATE: MA ZIP: 02494 BUSINESS PHONE: 7814330771 MAIL ADDRESS: STREET 1: 119 FOURTH AVE CITY: NEEDHAM STATE: MA ZIP: 021942725 FORMER COMPANY: FORMER CONFORMED NAME: T CELL SCIENCES INC DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MARSH HENRY C JR CENTRAL INDEX KEY: 0001258764 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15006 FILM NUMBER: 08681014 BUSINESS ADDRESS: STREET 1: 297 SUMMER AVENUE CITY: READING STATE: MA ZIP: 01867 4 1 edgar.xml FORM 4 - X0202 4 2008-03-07 1 0000744218 AVANT IMMUNOTHERAPEUTICS INC AVAN 0001258764 MARSH HENRY C JR 297 SUMMER AVENUE READING MA 01867 0 1 0 0 V.P. Research Incentive Stock Option 8.16 2008-03-07 4 A 0 41666 8.16 A 2015-03-07 Common Stock 41666 41666 D Incentive Stock Option 20.06 2008-03-07 4 M 0 1250 20.06 A 2002-12-09 2008-12-09 Common Stock 1250 1250 D This option was granted for 500,000 shares at an exercise price of $0.68 per share, but was adjusted to reflect the one-for-twelve reverse stock split that occurred on March 7, 2008. 25% of the shares vest annually over the first four years. 101,000 options granted under the AVANT 1999 Stock Option and Incentive Plan were cancelled according to their terms for no consideration on March 7, 2008. This option was previously reported as covering 15,000 shares at an exercise price of $1.672 per share, but was adjusted to reflect the one-for-twelve reverse stock split that occurred onmarch 7, 2008. Henry Marsh 2008-03-11 -----END PRIVACY-ENHANCED MESSAGE-----